164,538 page views of this website between February 1st 2018 and 30th November 2018.
42,687 key individuals such as policymakers and academics throughout the EU and the rest of the world currently receive this publication.
To verify the above or to gain more detailed statistics please contact Stephanie Davies, our Head of Operations.
EU HEALTHCARE & SOCIAL CARE NEWS
EVENT PARTNERS
Event Partners
Latest Publication
Health Europa Quarterly Issue 07
Exploring the rapidly changing environment of healthcare, Health Europa Quarterly issue 07 delves into environmental and climate-related harm and discusses the evolution of medical...
LATEST HEALTH EBOOKS
Understanding mucopolysaccharide storage diseases
What are mucopolysaccharide storage diseases? What are their signs and symptoms? And what treatment options are available for patients?
These are just some of the...
Institute for Cardiogenetics – unravelling the genetics of cardiovascular disease
Cardiovascular disease (CVD) is a major global killer, but little is known about the exact causes. The Institute for Cardiogenetics aims to understand the...
The MPS Society: supporting those with mucopolysaccharidoses
Being diagnosed and living with mucopolysaccharidoses is life changing. The Austrian MPS Society, MPS Austria, is an organisation which supports families and their individuals...
Pfalzklinikum – a look into the everyday workings of a mental...
Mental health is one of the biggest health issues in the world, with many people suffering from an array of life-changing and debilitating conditions...
LATEST PARTNERS
Promoting anti-tumour immune responses
The development of strategies targeting immunosuppressive cells, molecules and pathways with less toxicity and with a more universal role in tumour progression is an...
Developers of the first tissue engineering product in urology
UroTiss Europe GmbH, a biotech company with headquarters in Dortmund, Germany, has developed an innovative and gentle method for the surgical repair of urethral...
Global medical cannabis leader across five continents
Tilray (Nasdaq: TLRY) is a global leader in medical cannabis research, cultivation, processing and distribution. We aspire to lead, legitimise and define the future of...
Institute for Cardiogenetics: at the forefront of cardiovascular genomics research
Atherosclerosis and its most disabling sequelae, coronary artery disease (CAD) and myocardial infarction (MI), are leading causes of death in Europe. Until now, preventive...
